Novavax (NVAX) Acquisitions (2013 - 2020)
Novavax's (NVAX) quarterly Acquisitions came in at $1.3 million in Q4 2020, up 143.24% quarter-over-quarter from -$3.0 million in Q4 2013.
Novavax (NVAX) Acquisitions (2013 - 2020) Analysis & Trends
Novavax's Acquisitions history runs 2 years deep, the most recent figure standing at $1.3 million for Q4 2020.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $1.3 million in Q4 2020; TTM through Dec 2021 was $1.3 million, a 0.0% change from a year earlier, with the FY2020 full-year figure at $165.5 million, changed N/A from the prior year.
- Acquisitions grew to $1.3 million in Q4 2020 per NVAX's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $1.3 million in Q4 2020 and bottomed at $1.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.31 Mn |
| Dec 31, 2013 | -3.03 Mn |